ARCHIVES

FDA Proposes “Clarification” Of Clinical Studies regulations, Including Sanctions, Inspections

This article is from The Cancer Letter archive.

Vol. 04 No. 33 | August 18, 1978

Download PDF Visit The Full Archive

Related Articles

Cancer Policy Board urges distinct care for cancer survivors.

November 11, 2005

Drug Approvals: FDA grants accelerated approval for Keytruda in metastatic melanoma

September 5, 2014

NIH Chemical Genomics Center to screen small molecules.

June 18, 2004

Olaparib, A PARP Inhibitor, Can Reduce Tumor Size In Advanced Ovarian Cancer

August 27, 2010

NCI clinical trials cooperative group chairmen reject specimen bank contract proposal, endorse cooperative agreements;

January 2, 2004

Cooperative Groups: Insurers Agree To Cover Patient Care Costs In Group Trials

September 26, 1997